DMOADs and DMARDs in the treatment of patients with joint and spine diseases
The data on the classification of drugs, which are prescribed for the treatment of patients with joint and spine diseases, such as osteoarthritis (OA) and rheumatoid arthritis (RA), are presented. The groups of drugs widely used in clinical practice are disease-modifying osteoarthritis drugs (DMOADs...
Saved in:
Main Author: | O. A. Shavlovskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2024-02-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/937 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-11-01) -
From misconceptions to reasonable osteoarthritis patients therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-07-01) -
On the prospects for the use of undenatured type II collagen in the treatment of osteoarthritis and other joint diseases
by: O. A. Gromova, et al.
Published: (2022-08-01) -
On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis
by: I. V. Sarvilina, et al.
Published: (2024-08-01) -
Evidence base of pharmaconutraceuticals with chondroprotective action
by: O. A. Shavlovskaya, et al.
Published: (2024-04-01)